Back

20/20 BioLabs reschedules investor webinar to Sept. 2 at 2 p.m.

Verifying
  • 20/20 BioLabs rescheduled its investor webinar to September 2, 2026.
  • OneTest revenue reached $0.7 million, increasing 47.1% year over year.
  • Management will discuss quarterly results, firefighter screening and commercial expansion during the webinar.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.